Eris Biotech
YC W24 · Active · Our drugs engage the immune system to fight tumors
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW24 | |
| Other | Active | YCW22 | |
| Other | Active | YCS22 | |
| Other | Active | YCS24 | |
| Other | Active | YCW24 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW22 | |
| Other | Active | YCW24 | |
| Other | Active | YCW21 | |
| Other | Active | YCW23 | |
| AI | Active | YCW20 |
Also from W24
All of W24About Eris Biotech
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
- YC batch
- W24 · Winter 2024
- Status, per YC
- Active
- Category
- Other
- Team size
- 2
- Location
- Lehi, UT, USA
- Checked
- 34m ago
YC tags: Biotech, Therapeutics, Drug discovery, Oncology
Eris Biotech: questions
Which YC batch was Eris Biotech in?
Eris Biotech was in Y Combinator's Winter 2024 batch (W24).
Is Eris Biotech still active?
Y Combinator lists Eris Biotech as active.
Where is Eris Biotech based?
Eris Biotech lists Lehi, UT, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.